ask="51.05"
ask_size="700"
average_daily_volume="956837"
bid="N/A"
bid_size="N/A"
book_value="10.71"
change="-0.25"
change_from_200_day_moving_average="2.05"
change_from_50_day_moving_average="5.16"
change_from_52_week_high="-29.63"
change_From_52_week_low="19.10"
change_in_percent="-0.49%"
close="50.48"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.79"
ebitda="-409.46M"
eps_estimate_current_year="-5.08"
eps_estimate_next_quarter="-1.31"
eps_estimate_next_year="-4.69"
ex_dividend_date="N/A"
float_shares="71077000"
high="51.09"
high_52_weeks="80.11"
last_trade_date="3/13/2017"
last_trade_price="50.48"
last_trade_size="39359"
last_trade_time="4:00pm"
low="49.89"
low_52_weeks="31.38"
market_capitalization="4.34B"
moving_average_200_day="48.43"
moving_average_50_day="45.32"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="66.40"
open="51.09"
pe_ratio="N/A"
peg_ratio="-0.22"
percent_change_from_200_day_moving_average="+4.23%"
percent_change_from_50_day_moving_average="+11.38%"
percent_change_from_52_week_high="-36.99%"
percent_change_from_52_week_low="+60.87%"
previous_close="50.73"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.74"
price_per_sales="92.53"
revenue="47.16M"
shares_outstanding="86013000"
short_ratio="10.31"
stock_exchange="NMS"
symbol="ALNY"
volume="637093"
weeks_range_52="31.38 - 80.11"
